GRN Variant rs5848 Reduces Plasma and Brain Levels of Granulin in Alzheimer's Disease Patients

被引：37

作者：

Kamalainen, Anna ^{[1
]}

Viswanathan, Jayashree ^{[1
]}

Natunen, Teemu ^{[1
]}

Helisalmi, Seppo ^{[1
]}

Kauppinen, Tarja ^{[1
]}

Pikkarainen, Maria ^{[1
]}

Pursiheimo, Juha-Pekka ^{[2
]}

Alafuzoff, Irina ^{[3
,4
]}

Kivipelto, Miia ^{[1
,5
,6
]}

Haapasalo, Annakaisa ^{[1
]}

Soininen, Hilkka ^{[1
,7
]}

Herukka, Sanna-Kaisa ^{[1
,7
]}

Hiltunen, Mikko ^{[1
]}

机构：

[1] Univ Eastern Finland, Inst Clin Med Neurol, FI-70211 Kuopio, Finland

[2] Univ Turku, Turku Ctr Biotechnol, Turku, Finland

[3] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden

[4] Univ Uppsala Hosp, Uppsala, Sweden

[5] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Aging Res Ctr, Stockholm, Sweden

[6] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Alzheimers Dis Res Ctr, Stockholm, Sweden

[7] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland

来源：

JOURNAL OF ALZHEIMERS DISEASE | 2013年 / 33卷 / 01期

基金：

芬兰科学院;

关键词：

Alzheimer's disease; granulin; GRN; microRNA; plasma; rs5848; temporal cortex; FRONTOTEMPORAL DEMENTIA; RISK; GENE;

D O I：

10.3233/JAD-2012-120946

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Genetic variants in the granulin (GRN) gene have been shown to increase the risk of Alzheimer's disease (AD). Here, we report that the A allele of rs5848 in GRN reduces plasma granulin levels in a dose-dependent manner in a clinically-defined AD sample cohort. Similarly, the mRNA levels of granulin were decreased with respect to A allele of rs5848 in the inferior temporal cortex of neuropathologically confirmed AD patients. Our findings suggest that the A allele of rs5848 is functionally relevant by reducing the expression of granulin.

引用

页码：23 / 27

页数：5

共 50 条

[41] Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease
Giannisis, Andreas
Al-Grety, Asma
Carlsson, Henrik
Patra, Kalicharan
Twohig, Daniel
Sando, Sigrid Botne
Lauridsen, Camilla
Berge, Guro
Grontvedt, Goril Rolfseng
Brathen, Geir
White, Linda R.
Kultima, Kim
Nielsen, Henrietta M.
ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
[42] Brain oestradiol and testosterone levels in Alzheimer's disease
Twist, SJ
Taylor, GA
Weddell, A
Weightman, DR
Edwardson, JA
Morris, CM
NEUROSCIENCE LETTERS, 2000, 286 (01) : 1 - 4
[43] Biomonitoring of Mycotoxins in Plasma of Patients with Alzheimer's and Parkinson's Disease
Arce-Lopez, Beatriz
Alvarez-Erviti, Lydia
De Santis, Barbara
Izco, Maria
Lopez-Calvo, Silvia
Eugenia Marzo-Sola, Maria
Debegnach, Francesca
Lizarraga, Elena
Lopez de Cerain, Adela
Gonzalez-Penas, Elena
Vettorazzi, Ariane
TOXINS, 2021, 13 (07)
[44] Cerebrospinal fluid nitrate levels in patients with Alzheimer's disease
Navarro, JA
Molina, JA
JimenezJimenez, FJ
BenitoLeon, J
OrtiPareja, M
Gasalla, T
CabreraValdivia, F
Vargas, C
deBustos, F
Arenas, J
ACTA NEUROLOGICA SCANDINAVICA, 1996, 94 (06): : 411 - 414
[45] Serum levels of aluminum in a group of patients with Alzheimer's disease
Gutierrez, Fernanda
Arcila, Victor
Quintero, Karmaria
Alvarez, Ruth
Querales, Marvin
ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2014, 48 (04): : 485 - 490
[46] Serum sEPCR Levels Are Elevated in Patients With Alzheimer's Disease
Zhu, Yongjian
Chen, Zhilong
Chen, Xugang
Hu, Sheng
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2015, 30 (05): : 517 - 521
[47] Cerebrospinal fluid carnitine levels in patients with Alzheimer's disease
Rubio, JC
de Bustos, F
Molina, JA
Jiménez-Jiménez, FJ
Benito-León, J
Martín, MA
Campos, Y
Ortí-Pareja, M
Cabrera-Valdivia, F
Arenas, J
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 155 (02) : 192 - 195
[48] Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer’s disease
Andreas Giannisis
Asma Al-Grety
Henrik Carlsson
Kalicharan Patra
Daniel Twohig
Sigrid Botne Sando
Camilla Lauridsen
Guro Berge
Gøril Rolfseng Grøntvedt
Geir Bråthen
Linda R. White
Kim Kultima
Henrietta M. Nielsen
Alzheimer's Research & Therapy, 14
[49] Neuropsychological assessment and cortisol levels in biofluids from early Alzheimer's disease patients
Pena-Bautista, C.
Baquero, M.
Ferrer, I
Hervas, D.
Vento, M.
Garcia-Blanco, A.
Chafer-Pericas, C.
EXPERIMENTAL GERONTOLOGY, 2019, 123 : 10 - 16
[50] Serum seladin-1 levels in diabetes mellitus and Alzheimer's disease patients
Onmez, Attila
Alpay, Merve
Torun, Serkan
Sahin, I. Ethem
Onec, Kursad
Degirmenci, Yildiz
ACTA NEUROLOGICA BELGICA, 2020, 120 (06) : 1399 - 1404

← 1 2 3 4 5 →